id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2014-D-0313-0004,FDA,FDA-2014-D-0313,"Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Draft Guidance for Industry, Researchers, Patient Groups, and Food and Drug Administration 
Staff on Meetings With the Office of Orphan Products Development",Notice,30 Day Proposed Information Collection,2014-12-18T05:00:00Z,2014,12,2014-12-18T05:00:00Z,2015-01-21T04:59:59Z,2015-07-09T14:25:12Z,2014-29612,0,0,0900006481982289
FDA-2014-D-0313-0001,FDA,FDA-2014-D-0313,"Draft Guidance for Industry, Researchers, Patient Groups, and
Food and Drug Administration Staff on Meetings With the Office of Orphan Products Development; Availability",Notice,Notice of Availability,2014-04-09T04:00:00Z,2014,4,2014-04-09T04:00:00Z,2014-06-10T03:59:59Z,2014-06-10T01:04:35Z,2014-07908,0,0,09000064816ab417
FDA-2014-D-0313-0002,FDA,FDA-2014-D-0313,"Draft Guidance for Industry, Researchers, Patient Groups, and
Food and Drug Administration Staff on Meetings With the Office of Orphan Products Development",Other,Guidance,2014-04-09T04:00:00Z,2014,4,2014-04-09T04:00:00Z,,2024-11-07T23:06:51Z,,1,0,09000064816aba26